COVID-19 Hypercoagulability: Pathophysiology
Back to course
Video Transcription
Video Summary
Asset Subtitle
Infection, Hematology, 2022
Asset Caption
COVID-19 has been shown to infect endothelial cells, which, along with inflammation, can lead to a hypercoagulable state. This session will review the pathophysiology of endotheliopathy and perturbation of coagulation in COVID-19, screening strategies for deep vein thrombosis and pulmonary embolism, evidence about timing and dosing of prophylactic and therapeutic anticoagulation, evidence for hyperviscosity, and the role of cytokine release in altered coagulation. Lessons learned from the COVID-19 pandemic may be applicable to other critically ill patients.
Meta Tag
Content Type Presentation
Knowledge Area Infection
Knowledge Area Hematology
Knowledge Level Intermediate
Knowledge Level Advanced
Membership Level Select
Tag Coagulation
Tag COVID-19
Year 2022
COVID-19 coagulopathy
coagulation cascade
endothelial damage
fibrinolytic shutdown
complement activation


Society of Critical Care Medicine

500 Midway Drive
Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847 439-7226

Contact Us

About SCCM


Advertising & Sponsorship




Patients & Families

Surviving Sepsis Campaign

Critical Care Societies Collaborative

kisspng-facebook-social-media-computer-icons-linkedin-soci-gray-5ac493cf1c2975.7867418415228323351154  - KW Symphony    Gray twitter 3 icon - Free gray social icons    Gray linkedin 3 icon - Free gray site logo icons    Gray instagram icon - Free gray social icons    YouTube Icon Gray Box - HONOR VETERANS NOW


© Society of Critical Care Medicine. All rights reserved.   |    Privacy Statement    |    Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.

Android App Download IOS App Download Powered By